Diffuse Large B-Cell Lymphoma
Laurie H. Sehn, Gilles Salles
Abstract
DLBCL, an aggressive cancer, accounts for about 30% of all lymphomas. Empirical combination chemotherapy cures about 65% of patients initially, with another 20 to 25% cured with salvage therapy. Efforts are ongoing to tailor therapy to particular genetic lesions.
Topics & Concepts
LymphomaDiffuse large B-cell lymphomaChemotherapySalvage therapyMedicineOncologyInternal medicineCancer researchCancer therapyCancerLymphoma Diagnosis and TreatmentCAR-T cell therapy researchChronic Lymphocytic Leukemia Research